About: Nowak is responsible for developing and managing the College’s new Center for Health and Risk Communication, which seeks to foster an interdisciplinary approach to health and risk-related Communication projects, including interventions, campaigns, messaging and messages, news media and provider-patient communication.
Dr. Nowak received his B.S. in 1982 from the University of Wisconsin-Milwaukee, with majors in both economics and communications. He continued his studies at the University of Wisconsin-Madison, where he subsequently earned an M.A. degree in journalism (1987) and a Ph.D. in the field of mass communications (1990).
Glen Nowak is a Professor of Advertising and Public Relations and director of the Grady College’s Center for Health and Risk Communication. Prior to joining the Grady faculty in January 2013, he worked 14 years at the Centers for Disease Control and Prevention. He spent six years as director of media relations at CDC and six years as communications director for CDC’s National Immunization Program. He has experience in managing and implementing health and risk communications programs, media relations, health information campaigns and social marketing. Prior to joining CDC in January 1999, Dr. Nowak was an associate professor of advertising and communication at the Grady College of Journalism and Mass Communication at the University of Georgia. At Georgia, Dr. Nowak taught undergraduate and graduate courses in principles of advertising, communication and advertising research, communication and advertising management, social marketing, and health communications. In the course of his career, Dr. Nowak has authored or co-authored a number of peer-reviewed journal articles on communications practices, social marketing, and health communications, and conducted numerous workshops and trainings on health communication, social marketing, risk communication and media relations.
Abstract: The epidemic of opioid drug use and misuse in the United States and in many other continues unabated. Communicating to healthcare practitioners, the public, news media, and those legally and illegally using opioids is unusually complex due to the multiple factors and varying use situations that have contributed to the current epidemic. To date, […]Read More
Abstract: Vaccines that would be recommended and offered in response to a novel influenza virus bring many communication challenges. This chapter identifies and describes some of the major issues that public health agencies and regulatory bodies, vaccine manufacturers, and healthcare professionals would face when it comes to pandemic influenza vaccines and immunization recommendations. It does […]Read More
Abstract: Given their influence and visibility, understanding how news media cover topics involving medicines and how they provide information to their target audiences is essential when it comes to medicinal product risk communication research. While information about health and medicine are found in entertainment and social media, this chapter introduces media science with a focus, […]Read More
Abstract: Epidemiologists and medical investigators deployed to disease outbreaks and public health investigations involving illness and deaths often need to communicate the journalists, local officials, and community members. This chapter identifies and describes the communication approaches and principles needed for effective communication. Drawing from professional experience and published research, this chapter provides epidemiologists and medical […]Read More
Abstract: While it seems intuitive that highly visible vaccine-preventable disease outbreaks should impact perceptions of disease risk and facilitate vaccination, few empirical studies exist to confirm or dispel these beliefs. This study investigates the impact of the 2014-15 Disneyland measles outbreak on parents’ vaccination attitudes and future vaccination intentions. The analysis relies on a pair […]Read More
Abstract: Glaxo Smith Kline’s Cervarix was the first human papillomavirus (HPV) vaccine licensed for use in China in July 2016 and officially launched there on July 31, 2017. Since news media content can influence people’s vaccine-related knowledge, understanding, and intentions, a content analysis was used to examine the information conveyed to the public about the […]Read More